COMMUNIQUÉS West-GlobeNewswire

OneMedNet Inks Agreement with a Global Top-10 Medical Technology Company
29/05/2024
OneMedNet’s new iRWD™ platform customer impacts more than 150 million patients each year MINNEAPOLIS, May 29, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading [...]
Fate Therapeutics to Present at 2024 Jefferies Global Healthcare Conference
29/05/2024
SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of [...]
Additional Data Showing Acoramidis Increases Serum Transthyretin Which is Associated with Improved Cardiovascular Outcomes Presented at ISA from BridgeBio Pharma’s Phase 3 ATTRibute-CM Study in Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
29/05/2024
- Acoramidis treatment resulted in increased serum transthyretin (TTR) levels by Day 28 that were sustained and were correlated with a reduced risk of all-cause mortality (ACM), cardiovascular mortality (CVM), and [...]
scPharmaceuticals to Present at the Jefferies Global Healthcare Conference
29/05/2024
BURLINGTON, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of [...]
Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024
29/05/2024
Following a recently completed Type B meeting with the FDA, Immunovant is on track to initiate 4 to 5 potentially registrational studies for its lead asset IMVT-1402 in endocrinology, neurology, and other therapeutic [...]
Cytokinetics to Participate in June Investor Conferences
29/05/2024
SOUTH SAN FRANCISCO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the company is scheduled to participate in the following investor conferences in June: [...]
Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference
29/05/2024
EMERYVILLE, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive [...]
Ori Biotech Unveils IRO Platform at Annual International Society for Cell & Gene Therapy Conference
29/05/2024
Innovative cell therapy manufacturing platform moving industry toward widespread patient access to life-saving cell and gene therapies LONDON, May 29, 2024 (GLOBE NEWSWIRE) -- Ori Biotech Ltd. (Ori), a leader in cell [...]
InnovAge Celebrates Grand Opening of Orlando’s First PACE Center in Partnership with Orlando Health
29/05/2024
PACE Program Provides Highly Coordinated, Personalized Senior Care ORLANDO, Fla., May 29, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), an industry leader in providing comprehensive [...]
AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS
29/05/2024
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION OF MASITINIB IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Paris, 29 May, 2024, 6pm CET AB Science SA (Euronext [...]
AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA
29/05/2024
COMMUNIQUE DE PRESSE AB SCIENCE FAIT LE POINT SUR LA DEMANDE D'AUTORISATION CONDITIONNELLE DE MISE SUR LE MARCHÉ DU MASITINIB DANS LE TRAITEMENT DE LA SCLÉROSE LATÉRALE AMYOTROPHIQUE Paris, 29 mai 2024, 18h AB Science [...]
Mise à disposition des documents préparatoires à l’Assemblée générale mixte du 19 juin 2024
29/05/2024
Mise à disposition des documents préparatoires à l’Assemblée générale mixte du 19 juin 2024 Nantes, le 29 mai 2024, 18 heures – OSE Immunotherapeutics SA ( ISIN: FR0012127173; Mnémo: OSE) annonce la mise en ligne des [...]
Zealand Pharma to participate in upcoming healthcare investor conferences in June 2024
29/05/2024
Press release – No. 5 / 2024 Zealand Pharma to participate in upcoming healthcare investor conferences in June 2024 Copenhagen, Denmark, May 29, 2024 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a [...]
BioStem Technologies to Sponsor MRO Better Half Dash
29/05/2024
POMPANO BEACH, Fla., May 29, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived [...]
Twin Cities Lyme Foundation and Bay Area Lyme Foundation Unite Efforts to Further Advance the Fight Against Tick-Borne Diseases
29/05/2024
Twin Cities Lyme Foundation Founder Lisa Najarian and her husband Former CNBC Correspondent Peter Najarian to join the Advisory Board of Bay Area Lyme Foundation PORTOLA VALLEY, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- [...]
Trading by management and close relations of management
29/05/2024
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of [...]
UPDATE -- Georgiamune Expands Cancer Treatment Pipeline with Two Novel Drugs Within Five Months of Launch
29/05/2024
Georgiamune receives U.S. FDA clearance for GIM-531 and continues to enroll patients in clinical trial testing for GIM-122 GAITHERSBURG, Md., May 29, 2024 (GLOBE NEWSWIRE) -- Today, Georgiamune Inc. , a privately held, [...]
AMN Healthcare Launches Market Insights into ShiftWise Flex: Empowering Healthcare Talent Strategy with Dynamic Intelligence
29/05/2024
DALLAS, May 29, 2024 (GLOBE NEWSWIRE) -- ShiftWise Flex, a next-gen vendor neutral vendor management system (VMS) that serves as a comprehensive workforce management platform for healthcare organizations, announces the [...]
TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138
29/05/2024
BOSTON, May 29, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced new preliminary data [...]

Pages